Clear Harbor Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.23 Billion
- Q4 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 5,421 shares of REGN stock, worth $3.69 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
5,421
Previous 2,415
124.47%
Holding current value
$3.69 Million
Previous $2.54 Million
52.13%
% of portfolio
0.31%
Previous 0.21%
Shares
16 transactions
Others Institutions Holding REGN
# of Institutions
1,516Shares Held
82.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.35 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.76 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.1 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.34 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.93 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $73.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...